Mark Reynolds's Net Worth
-$153 Thousand
Who is Mark Reynolds?
Mark Reynolds does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GeoVax Labs, Inc., and DUSKA THERAPEUTICS, INC..
SEC CIK
Mark Reynolds's CIK is 0001298237
Past Insider Trading and Trends
2010 was Mark Reynolds's most active year for acquiring shares with 8 total transactions. Mark Reynolds's most active month to acquire stocks was the month of November. 2020 saw Mark Reynolds paying a total of $300,920.00 for 120,368 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GeoVax Labs, Inc. (GOVX) Snapshot price: $2.63
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.37% | 2K |
$2.77 | $5,540.00 | 7.21K |
Feb 7
| |||
Form 4
| +14.67% | 10K |
$0.52 | $5,179.00 | 78.18K |
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
| +13.29% | 8K |
$0.63 | $5,040.00 | 68.18K |
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
∞
| 60.18K |
$5.00 | $300,920.00 | 60.18K |
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
| +83.33% | 30K |
$0.17 | $5,215.00 | 66K |
Apr 22 - Apr 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
| +71.43% | 15K |
$0.67 | $10,050.00 | 36K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
| +250.00% | 15K |
$0.67 | $10,050.00 | 21K |
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
| +20.00% | 1K |
$2.50 | $2,500.00 | 6K |
Jul 2
| |||
Form 4
| +72.65% | 2.1K |
$3.32 | $6,982.46 | 5K |
Jun 9
| |||
Form 4
| +37.90% | 796 |
$3.60 | $2,865.60 | 2.9K |
May 20
| |||
Form 4
| +250.00% | 1.5K |
$3.32 | $4,975.00 | 2.1K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
∞
| 30K |
$0.17 | $5,040.00 | 30K |
Dec 5 - Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DUSKA THERAPEUTICS, INC. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||